Table A1.
Characteristic | Observation |
Rituximab Monotherapy |
Chemotherapy |
Rituximab Chemotherapy |
XRT |
Clinical Trial |
Other |
Total |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | |
No. of patients | 484 | 378 | 86 | 1,415 | 154 | 167 | 44 | 2,728 | ||||||||
FLIPI | ||||||||||||||||
Low, 0–1 | 156 | 21.3 | 89 | 12.1 | 19 | 2.6 | 334 | 45.6 | 92 | 12.6 | 33 | 4.5 | 10 | 1.4 | 733 | 100 |
Intermediate, 2 | 135 | 20.0 | 92 | 13.6 | 25 | 3.7 | 340 | 50.4 | 10 | 1.5 | 64 | 9.5 | 9 | 1.3 | 675 | 100 |
High, 3–5 | 59 | 9.2 | 90 | 14.0 | 22 | 3.4 | 404 | 62.8 | 5 | 0.8 | 52 | 8.1 | 11 | 1.7 | 643 | 100 |
Unknown | 134 | 19.8 | 107 | 15.8 | 20 | 3.0 | 337 | 49.8 | 47 | 6.9 | 18 | 2.7 | 14 | 2.1 | 677 | 100 |
Histology by grade | ||||||||||||||||
1 | 282 | 24.6 | 193 | 16.8 | 34 | 3.0 | 459 | 40.0 | 76 | 6.6 | 82 | 7.1 | 21 | 1.8 | 1,147 | 100 |
2 | 115 | 15.0 | 108 | 14.1 | 25 | 3.3 | 404 | 52.7 | 46 | 6.0 | 54 | 7.0 | 14 | 1.8 | 766 | 100 |
3 | 47 | 9.4 | 41 | 8.2 | 17 | 3.4 | 355 | 70.9 | 13 | 2.6 | 24 | 4.8 | 4 | 0.8 | 501 | 100 |
Multiple histology | 2 | 3.8 | 3 | 5.8 | 2 | 3.8 | 44 | 84.6 | 0 | 0.0 | 1 | 1.9 | 0 | 0.0 | 52 | 100 |
Unknown | 38 | 14.5 | 33 | 12.6 | 8 | 3.1 | 153 | 58.4 | 19 | 7.3 | 6 | 2.3 | 5 | 1.9 | 262 | 100 |
Stage | ||||||||||||||||
I | 136 | 28.7 | 61 | 12.9 | 12 | 2.5 | 144 | 30.4 | 111 | 23.4 | 0 | 0.0 | 10 | 2.1 | 474 | 100 |
II | 84 | 20.1 | 70 | 16.8 | 16 | 3.8 | 209 | 50.1 | 24 | 5.8 | 6 | 1.4 | 8 | 1.9 | 417 | 100 |
III | 148 | 18.5 | 121 | 15.1 | 29 | 3.6 | 430 | 53.6 | 4 | 0.5 | 59 | 7.4 | 11 | 1.4 | 802 | 100 |
IV | 115 | 11.4 | 123 | 12.1 | 28 | 2.8 | 620 | 61.2 | 12 | 1.2 | 101 | 10.0 | 14 | 1.4 | 1,013 | 100 |
Unknown | 1 | 4.5 | 3 | 13.6 | 1 | 4.5 | 12 | 54.5 | 3 | 13.6 | 1 | 4.5 | 1 | 4.5 | 22 | 100 |
Region | ||||||||||||||||
Midwest | 149 | 17.3 | 118 | 13.7 | 18 | 2.1 | 435 | 50.5 | 59 | 6.8 | 69 | 8.0 | 14 | 1.6 | 862 | 100 |
Northeast | 136 | 29.0 | 63 | 13.4 | 15 | 3.2 | 182 | 38.8 | 28 | 6.0 | 40 | 8.5 | 5 | 1.1 | 469 | 100 |
Southeast | 109 | 13.3 | 109 | 13.3 | 40 | 4.9 | 474 | 57.7 | 42 | 5.1 | 33 | 4.0 | 15 | 1.8 | 822 | 100 |
Southwest | 35 | 16.7 | 18 | 8.6 | 6 | 2.9 | 131 | 62.7 | 9 | 4.3 | 4 | 1.9 | 6 | 2.9 | 209 | 100 |
West | 55 | 15.0 | 70 | 19.1 | 7 | 1.9 | 193 | 52.7 | 16 | 4.4 | 21 | 5.7 | 4 | 1.1 | 366 | 100 |
Site type | ||||||||||||||||
Academic | 112 | 20.9 | 61 | 11.4 | 18 | 3.4 | 238 | 44.5 | 30 | 5.6 | 70 | 13.1 | 6 | 1.1 | 535 | 100 |
Community | 372 | 17.0 | 317 | 14.5 | 68 | 3.1 | 1,177 | 53.7 | 124 | 5.7 | 97 | 4.4 | 38 | 1.7 | 2,193 | 100 |
Abbreviations: FLIPI, Follicular Lymphoma International Prognostic Index; XRT, external-beam radiotherapy.